Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 51-61
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.51
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.51
Univariate | |||
OR | 95%CI | P value | |
Total tumor diameter | |||
≥ 5 cm | 3.19 | 1.18-8.59 | 0.022 |
Tumor type | |||
Solitary HCC | Reference | - | - |
Multinodular HCC | 1.17 | 0.52-2.66 | 0.71 |
Diffuse-infiltrative HCC | 1.06 | 0.13-8.43 | 0.96 |
Vascular invasion | 1.86 | 0.53-6.51 | 0.33 |
HBV infection | 1.76 | 0.73-4.26 | 0.21 |
Number of nodules | 1.21 | 0.92-1.59 | 0.18 |
Stage of liver disease | |||
Normal or precirrhotic liver | Reference | - | - |
Child-Pugh A | 2.29 | 0.51-10.2 | 0.28 |
Child-Pugh B | 1.22 | 0.23-6.47 | 0.81 |
Child-Pugh C | 1.14 | 0.19-7.01 | 0.89 |
AFP level | |||
> 100 ng/mL | 1.30 | 0.59-2.85 | 0.52 |
> 200 ng/mL | 1.59 | 0.72-3.50 | 0.25 |
> 400 ng/mL | 1.48 | 0.64-3.39 | 0.36 |
> 1000 ng/mL | 1.91 | 0.81-4.52 | 0.14 |
- Citation: Ekinci O, Baran B, Ormeci AC, Soyer OM, Gokturk S, Evirgen S, Poyanli A, Gulluoglu M, Akyuz F, Karaca C, Demir K, Besisik F, Kaymakoglu S. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma. World J Hepatol 2018; 10(1): 51-61
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/51.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.51